Lista de obras -

A micelle-shedding thermosensitive hydrogel as sustained release formulation.

artículo científico publicado en 2012

Antivascular therapies: targets beyond the vessel wall

artículo científico publicado en 2007

Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis

artículo científico publicado en 2008

Connective Tissue Growth Factor Is Related to All-cause Mortality in Hemodialysis Patients and Is Lowered by On-line Hemodiafiltration: Results from the Convective Transport Study

scientific article published on 13 May 2019

Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis

artículo científico publicado en 2011

Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres

artículo científico publicado en 2011

Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy

artículo científico publicado en 2006

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

artículo científico publicado en 2015

DNA Nuclear Targeting Sequences for Non-Viral Gene Delivery ⬇️

artículo científico publicado el 18 de marzo de 2011

Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology

artículo científico publicado en 2006

Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue

artículo científico publicado en 2011

Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases

artículo científico publicado en 2002

Diverse origins of the myofibroblast—implications for kidney fibrosis

artículo científico publicado en 2015

Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment

artículo científico publicado en 2016

Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.

artículo científico publicado en 2016

Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction

artículo científico publicado en 2015

Epac-Rap signaling reduces oxidative stress in the tubular epithelium

artículo científico publicado en 2014

Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels

artículo científico publicado en 2006

Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses

artículo científico publicado en 2014

Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating

artículo científico publicado en 2017

Gene based therapies for kidney regeneration

artículo científico publicado en 2016

Gold nanoparticles in theranostic oncology: current state-of-the-art ⬇️

artículo científico publicado el 16 de agosto de 2012

How to screen non-viral gene delivery systems in vitro? ⬇️

artículo científico publicado el 7 de mayo de 2011

Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative

artículo científico publicado en 2007

In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium

artículo científico publicado en 2003

Instability Mechanisms of Water-in-Oil Nanoemulsions with Phospholipids: Temporal and Morphological Structures.

artículo científico publicado en 2017

Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors

artículo científico publicado en 2008

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status

artículo científico

Locoregional cancer therapy using polymer-based drug depots.

artículo científico publicado en 2016

Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells

artículo científico publicado en 2012

Nanomedicines as cancer therapeutics: current status.

artículo científico

Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs

artículo científico publicado en 2008

Oxidative stress in obstructive nephropathy

scientific article published on 27 August 2010

Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents

artículo científico

RGD-avidin-biotin pretargeting to alpha v beta 3 integrin enhances the proapoptotic activity of TNF alpha related apoptosis inducing ligand (TRAIL).

artículo científico publicado en 2008

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

artículo científico publicado en 2005

Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.

artículo científico publicado en 2006

Selection and fabrication of a non-woven polycarbonate urethane cover for a tissue engineered airway stent

artículo científico publicado en 2016

Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate.

artículo científico publicado en 2002

Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges

artículo científico publicado en 2016

Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection

artículo científico publicado en 2012

Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier System

artículo científico publicado en 2015

Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies.

artículo científico

Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles.

artículo científico publicado en 2013

Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells ⬇️

artículo científico publicado el 31 de enero de 2012

Targeting podocyte-associated diseases.

artículo científico publicado en 2010

Targeting tumors with nanobodies for cancer imaging and therapy.

artículo científico publicado en 2013

The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.

artículo científico publicado en 2011

Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment

artículo científico publicado en 2011

Utility of Intravenous Curcumin Nanodelivery Systems for Improving <i>In Vivo</i> Pharmacokinetics and Anticancer Pharmacodynamics

scientific article published in 2022

Lista de obras de

A micelle-shedding thermosensitive hydrogel as sustained release formulation.

Antivascular therapies: targets beyond the vessel wall

Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis

Connective Tissue Growth Factor Is Related to All-cause Mortality in Hemodialysis Patients and Is Lowered by On-line Hemodiafiltration: Results from the Convective Transport Study

Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis

Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres

Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

DNA Nuclear Targeting Sequences for Non-Viral Gene Delivery ⬇️

Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology

Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue

Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases

Diverse origins of the myofibroblast—implications for kidney fibrosis

Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment

Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.

Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction

Epac-Rap signaling reduces oxidative stress in the tubular epithelium

Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels

Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses

Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating

Gene based therapies for kidney regeneration

Gold nanoparticles in theranostic oncology: current state-of-the-art ⬇️

How to screen non-viral gene delivery systems in vitro? ⬇️

Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative

In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium

Instability Mechanisms of Water-in-Oil Nanoemulsions with Phospholipids: Temporal and Morphological Structures.

Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status

Locoregional cancer therapy using polymer-based drug depots.

Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells

Nanomedicines as cancer therapeutics: current status.

Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs

Oxidative stress in obstructive nephropathy

Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents

RGD-avidin-biotin pretargeting to alpha v beta 3 integrin enhances the proapoptotic activity of TNF alpha related apoptosis inducing ligand (TRAIL).

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.

Selection and fabrication of a non-woven polycarbonate urethane cover for a tissue engineered airway stent

Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate.

Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges

Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection

Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier System

Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies.

Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles.

Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells ⬇️

Targeting podocyte-associated diseases.

Targeting tumors with nanobodies for cancer imaging and therapy.

The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.

Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment

Utility of Intravenous Curcumin Nanodelivery Systems for Improving <i>In Vivo</i> Pharmacokinetics and Anticancer Pharmacodynamics